Skip to content

The effect of pregnancy for development and progression of VHL-related tumors

The effect of pregnancy for development and progression of VHL-related tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018665
Enrollment
Unknown
Registered
2018-10-02
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Von Hippel-Lindau disease

Interventions

Case series:Nil

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18 to 45 years at the reproductive age; 2. Patients were confirmed to have VHL disease using clinical and/or genetic criteria; 3. Women with baby plans over the next two years; 4. Women who can cooperate with the long-term follow-up, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are receiving targeting therapy; 2. Patients with severity disorders,e.g. renal insufficiency(serum creatinine clearance >120 mmol/L), cardiac malfunction(NYHA-IV grade); severe allergy to Gd.0; 3. Refuse to sign informed consent or could not be reached within 3 months after enrollment; 4. Contradiction to MRI examinations; 5. Mental and communication disorders.

Design outcomes

Primary

MeasureTime frame
Size of tumors or cysts;

Countries

China

Contacts

Public ContactKan GONG

Peking University First Hospital

gongkan_pku@126.com+86 13910394281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026